🇺🇸 FDA
Pipeline program

Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT)

Phase 3 small_molecule active

Quick answer

Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT) for Symptomatic articular cartilage lesion of the knee (femoral condyles or trochlea) is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Symptomatic articular cartilage lesion of the knee (femoral condyles or trochlea)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials